118th Congress · HOUSE RESOLUTIONBILL

H.Res. 1039Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

Health
Introduced Feb 29, 2024
Last action Mar 8, 2024
Pipeline · Resolution
Step 1
Introduced
Feb 29, 2024
Step 2
Referred
Mar 8, 2024
E&C
Step 3
Committee
Step 4
House floor
SummaryCRS Summary

This resolution recognizes that Charcot-Marie-Tooth (CMT) disease is significant and expresses the sense that CMT should receive robust funding for research. CMT disease is a neurological disorder that causes damage to the peripheral nerves.

Provisions · 1 sectionsIntroduced in House
Timeline · 3 actions
Mar 8, 2024
Referred to the Subcommittee on Health.
Feb 29, 2024
Introduced in House
Feb 29, 2024
Referred to the House Committee on Energy and Commerce.